Anthropic IPO investors weigh cutting target valuation from ~$2T to $1.5T despite $16.8B quarter

According to reporting on October 18, some investors in Anthropic's planned November IPO are now discussing a valuation around $1.5 trillion, down from the roughly $2 trillion figure that had circulated. The fundamentals are not the problem on the surface. Anthropic reported Q3 revenue of $16.8B, a 45% quarter-over-quarter increase that would be remarkable at any scale, let alone for a company approaching listing.

The gap between growth and price reflects how public-market investors value frontier labs differently from late-stage private rounds. Public buyers anchor on revenue multiples, margin trajectory and the cost of compute commitments. They are less swayed by strategic scarcity. A $500B trim is a negotiation over how much of future growth gets priced in today, not a verdict that the business is weakening. Enterprise cost signals this week add some texture: Accenture's decision to cap central Claude funding at $29 per employee shows big customers are starting to manage spend actively.

The macro mood matters too. This week Gartner estimated that more than $3.5 trillion of AI infrastructure spending "could be exposed to impairment" by 2030 and predicted most specialized AI clouds won't survive independently. Hyperscaler executives, including AWS's CFO, have pushed back publicly and argued the spending is paying off. Anthropic's IPO will be the first big public test of whether investors buy that argument for a pure-play model lab.

Caveats: these are investor deliberations reported secondhand, not a filed price range. Final pricing depends on the roadshow, market conditions in November and how Anthropic presents compute obligations in its disclosures. The newly announced Public Benefit Fund, which ties share grants to valuation increases, will also need to be modeled as dilution. Watch for an updated S-1 or a price range. That is when the $1.5T versus $2T question resolves.